Hepatitis C virus-NS3P in relation to p53, p21waf, mdm2, p21-ras and c-erbB2 in hepatocarcinogenesis

被引:9
作者
Bahnassi, AA
Zekri, ARN
El-Houssini, S
Mokhtar, NM
Abdel-Aziz, AO
Sherif, GM
El-Mishad, AM
Khaled, HM
机构
[1] Cairo Univ, Natl Canc Inst, Dept Canc Biol, Virol & Immunol Unit, Cairo 11796, Egypt
[2] Cairo Univ, Natl Canc Inst, Dept Pathol, Cairo 11796, Egypt
[3] Cairo Univ, Kasr El Aini Sch Med, Dept Gastroenterol, Cairo 11796, Egypt
[4] Cairo Univ, Kasr El Aini Sch Med, Dept Bacteriol, Cairo 11796, Egypt
[5] Cairo Univ, Natl Canc Inst, Dept Biostat & Epidemiol, Cairo 11796, Egypt
[6] Cairo Univ, Natl Canc Inst, Dept Med Oncol, Cairo 11796, Egypt
关键词
hepatitis C virus; hepatocellular carcinoma; non-structural protein of HCV; oncogenes; tumor suppressor genes;
D O I
10.1111/j.1440-1746.2005.04002.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The non-structural protein 3 (NS3P) of hepatitis C virus (HCV) genome was linked to the neoplastic transformation of normal hepatocytes in chronically infected patients. However, the exact mechanisms involved in this process are unidentified yet, especially in the Egyptian population where the commonest type is genotype 4. Methods: We investigated 32 HCV reverse transcriptase-polymerase chain reaction (RT-PCR) positive hepatocellular carcinoma (HCC) cases and 18 morphologically normal hepatic tissues distant to tumors (MNT) for the correlation between HCV-NS3P, p53, p21(waf), mdm2, p21ras and c-erbB2 and DNA content by immunohistochemistry and image analysis. Results: The NS3P expression was lower in HCC (65.6%) than in MNT (94.4%) patients. The expression level of studied genes in HCC was: p53 (56.25%), p21(waf) (43.7%), mdm2 (59.4%), p21-ras (73.3%) and c-erbB2 (75%). Whereas in MNT, it was 22.2, 61.1, 44.4, 41.2 and 77.8%, respectively. The NS3P expression showed a significant correlation with the presence of cirrhosis, chronic active hepatitis (CAH) and tumor grade (P < 0.05). c-erbB2 overexpression and p21(waf) loss were higher in MNT than in HCC patients, however, this did not reach a statistically significant level. There was a statistically significant correlation between NS3P, c-erbB2 and p21(waf) (P < 0.01). There was also a significant correlation between p21(waf) loss and CAH (P = 0.01) as well as between mdm2, c-erbB2 and cirrhosis (P = 0.025 and 0.001) in HCC cases. There was a statistically significant difference in the ploidy status between HCC and MNT, but there was no significant relationship between the ploidy status and other clinicopathological features. Conclusion: The carcinogenic effect of NS3P is probably exerted at an early stage of HCC possibly through a pathway involving c-erbB2 and p21(waf) alterations. In contrast, p53, p21ras and mdm2 alterations are late events in hepatocarcinogenesis and are usually associated with an aggressive phenotype. (C) 2005 Blackwell Publishing Asia Pty Ltd.
引用
收藏
页码:1731 / 1740
页数:10
相关论文
共 40 条
[1]   Apoptosis inhibitory activity of cytoplasmic p21Cip1/WAF1 in monocytic differentiation [J].
Asada, M ;
Yamada, T ;
Ichijo, H ;
Delia, D ;
Miyazono, K ;
Fukumuro, K ;
Mizutani, S .
EMBO JOURNAL, 1999, 18 (05) :1223-1234
[2]   DNA ploidy of liver biopsies from patients with liver cirrhosis and hepatocellular carcinoma: a flow cytometric analysis [J].
Attallah, AM ;
Tabll, AA ;
Salem, SF ;
El-Sadany, M ;
Ibrahim, TA ;
Osman, S ;
El-Dosoky, IM .
CANCER LETTERS, 1999, 142 (01) :65-69
[3]   Diverse patterns of recognition of hepatitis C virus core and nonstructural antigens by antibodies present in Egyptian cancer patients and blood donors [J].
Attia, MAM ;
Zekri, ARN ;
Goudsmit, J ;
Boom, R ;
Khaled, HM ;
Mansour, MT ;
deWolf, F ;
ElDin, HMA ;
Sol, CJA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (11) :2665-2669
[4]  
Ayllón V, 2000, MOL MEMBR BIOL, V17, P65
[5]   The NS3/4A proteinase of the hepatitis C virus: unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy [J].
Bartenschlager, R .
JOURNAL OF VIRAL HEPATITIS, 1999, 6 (03) :165-181
[6]   RAPID PURIFICATION OF HEPATITIS-B VIRUS-DNA FROM SERUM [J].
BOOM, R ;
SOL, CJA ;
HEIJTINK, R ;
WERTHEIMVANDILLEN, PME ;
VANDERNOORDAA, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (09) :1804-1811
[7]  
Feng D, 1998, Zhonghua Yi Xue Za Zhi, V78, P278
[8]  
HARITANI H, 1990, PATHOLOGY, V67, P2594
[9]  
Heinze T, 1999, ANTICANCER RES, V19, P2501
[10]   Reduced p21(WAF1/CIP1) expression and p53 mutation in hepatocellular carcinomas [J].
Hui, AM ;
Kanai, Y ;
Sakamoto, M ;
Tsuda, H ;
Hirohashi, S .
HEPATOLOGY, 1997, 25 (03) :575-579